Is your family feeling the impact
of Alzheimer’s disease psychosis?

The VISTA clinical study will assess whether an investigational drug (potential new treatment) can reduce psychotic symptoms (delusions or hallucinations) in people with Alzheimer’s disease.

If your physician has directed you to this webpage, they believe you or your loved one may be eligible to take part in the VISTA clinical study. You may otherwise have found this page from a web search. This website has been designed to help you understand more about the clinical study and whether it may be a good option for you.